河北医科大学学报
河北醫科大學學報
하북의과대학학보
JOURNAL OF HEBEI MEDICAL UNIVERSITY
2015年
4期
398-401
,共4页
侯亮%李雪梅%刘千红%姚树青
侯亮%李雪梅%劉韆紅%姚樹青
후량%리설매%류천홍%요수청
肾病%肾透析%预后
腎病%腎透析%預後
신병%신투석%예후
nephrosis%renal dialysis%prognosis
目的:探讨肾脏替代治疗(renal replacement therapy,RRT)开始时间对非糖尿病终末期肾病(non diabetic end stage renal disease,NDNESRD)患者临床预后的影响。方法选择首次行 RRT 的 NDNESRD 患者89例,根据开始 RRT 时估算的肾小球滤过率(estimated glomerular filtration rate,eGFR)将患者分为提前治疗组和延迟治疗组,以患者生存率为主要临床事件,以住院率以及心血管事件、血管通路并发症、透析模式转换和腹膜炎发生率为次要临床事件,随访5年。结果两组1、3、5年生存率差异无统计学意义(P =0.166、0.088、0.067)。两组住院率(35.7% vs 38.3%,P =0.667)、心血管事件发生率(14.3% vs 10.6%,P =0.089)、血管通路并发症发生率(21.2% vs 28.1%,P =0.682)及腹膜炎发生率(22.2% vs 26.7%,P =0.541)差异无统计学意义。结论早期开始RRT 对 NDNESRD 患者的临床预后没有明显的益处。
目的:探討腎髒替代治療(renal replacement therapy,RRT)開始時間對非糖尿病終末期腎病(non diabetic end stage renal disease,NDNESRD)患者臨床預後的影響。方法選擇首次行 RRT 的 NDNESRD 患者89例,根據開始 RRT 時估算的腎小毬濾過率(estimated glomerular filtration rate,eGFR)將患者分為提前治療組和延遲治療組,以患者生存率為主要臨床事件,以住院率以及心血管事件、血管通路併髮癥、透析模式轉換和腹膜炎髮生率為次要臨床事件,隨訪5年。結果兩組1、3、5年生存率差異無統計學意義(P =0.166、0.088、0.067)。兩組住院率(35.7% vs 38.3%,P =0.667)、心血管事件髮生率(14.3% vs 10.6%,P =0.089)、血管通路併髮癥髮生率(21.2% vs 28.1%,P =0.682)及腹膜炎髮生率(22.2% vs 26.7%,P =0.541)差異無統計學意義。結論早期開始RRT 對 NDNESRD 患者的臨床預後沒有明顯的益處。
목적:탐토신장체대치료(renal replacement therapy,RRT)개시시간대비당뇨병종말기신병(non diabetic end stage renal disease,NDNESRD)환자림상예후적영향。방법선택수차행 RRT 적 NDNESRD 환자89례,근거개시 RRT 시고산적신소구려과솔(estimated glomerular filtration rate,eGFR)장환자분위제전치료조화연지치료조,이환자생존솔위주요림상사건,이주원솔이급심혈관사건、혈관통로병발증、투석모식전환화복막염발생솔위차요림상사건,수방5년。결과량조1、3、5년생존솔차이무통계학의의(P =0.166、0.088、0.067)。량조주원솔(35.7% vs 38.3%,P =0.667)、심혈관사건발생솔(14.3% vs 10.6%,P =0.089)、혈관통로병발증발생솔(21.2% vs 28.1%,P =0.682)급복막염발생솔(22.2% vs 26.7%,P =0.541)차이무통계학의의。결론조기개시RRT 대 NDNESRD 환자적림상예후몰유명현적익처。
Objective To investigate the effect of initiation time on renal replacement therapy(RRT) for clinical prognosis of patients with non diabetic end stage renal disease (NDNESRD).Methods A total of 89 NDNESRD patients who started the first dialysis were classified into early-start group or late-start group according to estimated glomerular filtration rate(eGFR).The primary outcome was patient survival,and the secondary outcomes were hospitalization,cardiovascular events,vascular access complications,change of dialysis modality, and peritonitis.The follow-up period was five years.Results The survival rate showed no significant difference in the first,the third and the fifth years between the two groups(P =0.166, 0.088,0.067 ).Hospitalization (35.7% vs 38.3%,P = 0.667 ),cardiovascular events (14.3% vs 10.6%,P = 0.089),vascular access complications (21.2% vs 28.1%,P = 0.682)and peritonitis (22.2% vs 26.7%,P =0.541)were no difference between the two groups.Conclusion There was no significant clinical benefit comparing early versus late initiation of RRT.